Pharmacoproteomics Profiling of Plasma From β‐Thalassemia Patients in Response to Hydroxyurea Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacoproteomics Profiling of Plasma From β‐Thalassemia Patients in Response to Hydroxyurea Treatment

Published:2018-08-27 Issue:1 Volume:59 Page:98-106
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Zohaib Muhammad¹,Ansari Saqib H.²,Shamsi Tahir S.²,Zubarev Roman A.³⁴,Zarina Shamshad¹^ORCID

Affiliation:

1. National Center for ProteomicsUniversity of Karachi Karachi Pakistan

2. National Institute of Blood Diseases and Bone Marrow Transplantation Karachi Pakistan

3. Division of Physiological Chemistry I, Department of Medical Biochemistry and BiophysicsKarolinska Institutet Stockholm Sweden

4. Department of Pharmacological & Technological ChemistryI.M. Sechenov First Moscow State Medical University Moscow Russia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1297

Reference44 articles.

1. Global epidemiology of haemoglobin disorders and derived service indicators

2. 1 The population genetics of the haemoglobinopathies

3. Reactivation of fetal hemoglobin in patients with beta‐thalassemia;Olivieri NF;Semin Hematol,1996

4. Induction of Fetal Hemoglobin in the Treatment of Sickle Cell Disease and β Thalassemia

5. Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications;International Journal of Molecular Sciences;2024-04-12

2. Beta-Thalassemia: A Pharmacological Drug-Based Treatment;Drugs and Drug Candidates;2024-02-08

3. Analysis and Interpretation of Pharmacoproteomic Data;Pharmacoproteomics;2024

4. Molecular and cellular effects of in vivo chronic intravascular hemolysis and anti-inflammatory therapeutic approaches;Vascular Pharmacology;2023-06

5. Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia;Blood Advances;2022-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3